OncChats

In this series of OncChats: The Future of Pathology with AI, Toufic Kachaamy, MD, of City of Hope, Madappa Kundranda, MD, PhD, of Banner MD Anderson Cancer Center, and Kun-Hsing Yu, MD, PhD, of Harvard Medical School, explore how AI is transforming pathology.

In this series of OncChats: Coordinated Care in Breast Oncology, Jason Ye, MD, and Daphne B. Stewart, MD, of Keck Medicine of USC, discuss the impact of a multidisciplinary breast cancer clinic on patient-centered care, streamlined treatment planning, and access to innovative clinical trials.

In this series of OncChats: Moving the Needle in Undifferentiated Pleomorphic Sarcoma, experts discuss the multidisciplinary advances in treating undifferentiated pleomorphic sarcoma of the extremities, highlighting the benefits of combining pembrolizumab with radiation and surgery to improve disease-free survival.

In this series of OncChats: A Close Look at Clinical Trials in Oncology and Beyond, Christina Brennan, MD, and Richard D. Carvajal, MD, both of Northwell Health, discuss the state of clinical trials at Northwell Health and the need to integrate these efforts into standard cancer care. They also emphasized the need for education and awareness regarding participation, challenges faced with complex protocols, and more.

In this series of OncChats: Empowering Community Cancer Care, Amanda M. Woodworth, MD, of Keck Medicine of USC at Henry Mayo Newhall Hospital, and Anirudh Rai, MD, of Henry Mayo Newhall Hospital, highlight their collaborative efforts to improve cancer care in Santa Clarita, California, by emphasizing community-based treatment, education, and supportive programs for patients and survivors.

In this series of OncChats: Optimizing the Use of Bispecific Antibodies in Myeloma and Beyond, Saad Z. Usmani, MD, MBA, FACP, FASCO, and Tarun Wasil, MBBS, FACP, share insights on how to improve the management of patients with multiple myeloma who are receiving bispecific antibodies.

In this series of OncChats: Leveraging Immunotherapy in GI Malignancies, Toufic Kachaamy, MD, Sunil Sharma, MD, and Madappa Kundranda, MD, PhD, discuss early detection with multiomic assays and leveraging immunotherapy in gastrointestinal cancers.

In this series of OncChats: Reviewing Best Practices in the Surgical Management of Breast Cancer, Gladys Giron, MD, FACS, and Cristina Lopez-Peñalver, MD, both of Baptist Health South Florida, discuss the current recommendations for the surgical treatment of patients with stage III and IV breast cancer.

In this series of OncChats: Assessing the Promise of AI in Oncology, Toufic A. Kachaamy, MD, of City of Hope, and Douglas Flora, MD, LSSBB, FACCC, of St. Elizabeth Healthcare, discuss the latest updates with leveraging artificial intelligence in the field of oncology.

In this series of OncChats: Leveraging Endoscopic Ultrasound in Pancreatic Cancer, Toufic A. Kachaamy, MD, of City of Hope, Madappa Kundranda, MD, PhD, of Banner MD Anderson Cancer Center, and Tamas A. Gonda, MD, of NYU Langone, discuss the evolving role of endoscopic ultrasound in the realm of pancreatic cancer.

In this series of OncChats: Mapping Progress in Pancreatic Cancer Surgery, Horacio J. Asbun, MD, and Domenech Asbun, MD, both of Baptist Health South Florida, share recent advances made with surgical approaches for pancreatic cancer, the need for multidisciplinary care in this disease, and efforts being made to continue to improve outcomes for these patients.

In this series of OncChats: Examining the Promise of Multicancer Early Detection Tests, Toufic A. Kachaamy, MD, Madappa Kundranda, MD, PhD, and Niloy Jewel J. Samadder, MD, shed light on multicancer early detection tests and how they may affect the future of cancer screening.

In this series of OncChats: Examining LIFU-Aided Liquid Biopsy in Glioblastoma, Manmeet Singh Ahluwalia, MD, MBA, FASCO, and Michael W. McDermott, MD, both of Baptist Health South Florida, discuss research efforts examining the use of low-intensity focused ultrasound to improve outcomes in glioblastoma and beyond.

In this series of OncChats: Understanding Lynch Syndrome and Associated Cancer Risk, Fay Kastrinos, MD, MPH, of Columbia University Herbert Irving Comprehensive Cancer Center, discusses progress made with identifying Lynch syndrome, considerations for associated colon cancer risk, and prevention strategies as well as treatment advances made for this condition.

In this series of OncChats: Taking Organoids From Bench to Bedside Through Endoscopy in Pancreatic Cancer, Richard Burkhart, MD, Madappa Kundranda, MD, PhD, Toufic A. Kachaamy, MD, discuss the potential for personalized medicine with patient-derived organoids in locally advanced pancreatic cancer.

In this series of OncChats: Understanding Endoscopy in the Realm of GI Cancers, Madappa Kundranda, MD, PhD, and Toufic A. Kachaamy, MD, discuss the role of interventional endoscopy in the management of patients with gastrointestinal malignancies.

In this series of OncChats: Traveling Through the Lung Cancer Treatment Paradigm, Aaron Franke, MD, discuss novel treatment approaches and optimal adverse event management for patients with lung cancer.

In this series of Onchats: Unpacking Data From Pivotal Trials in Multiple Myeloma, Hamza Hashmi, MD, shares how he translates recent findings to clinical practice.

In this series of OncChats: Immunotherapy and You, John Nakayama, MD, and Ali Amjad, MD, discuss how to leverage immunotherapy in gynecologic cancers.

In this series of OncChats: Taking Action to Individualize Ovarian Cancer Care, John Nakayama, MD, and Christopher Morse, MD, discuss how to personalize treatment for patients with ovarian cancer.